Earnings History Data for BioLineRx Ltd. (BLRX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
BioLineRx Ltd.
Bioline RX Ltd. is a biopharmaceutical development company. BioLineRx is dedicated to building a portfolio of products for unmet medical needs or with advantages over currently available therapies. The Company's portfolio consists of clinical stage candidates including BL-1020 for schizophrenia , BL-1040, for treatment of patients following a myocardial infarction, BL-5010 for non-surgical removal of skin lesions, BL-1021 for neuropathic pain and BL-7040 for treating Inflammatory Bowel Disease. In addition, BioLineRx has many products in various pre-clinical development stages for a variety of indications, including central nervous system diseases, oncology, infectious diseases, cardiovascular and autoimmune diseases.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26-03-2024 | PM | BLRX | BioLineRx Ltd. | 73.84 | -0.15 | -0.22 | -0.09 | BioLineRx GAAP EPS of -$0.06, revenue of $4.8M [3/26/2024 7:02 AM] |
1.04 | -0.26 (-20.05%) |
1.18 | -0.12 (-9.24%) |
0.79 - 2.53 | 1,676,414 | 240,000 | 122,263 | ||
| 20-11-2023 | PM | BLRX | BioLineRx Ltd. | 114.45 | -0.30 | -0.18 | -0.15 | biolinerx GAAP EPS of -$0.01 [11/20/2023 7:03 AM] |
1.69 | 0.0 (0.00%) |
1.61 | -0.08 (-4.73%) |
0.55 - 2.53 | 305,831 | 380,000 | 24,320 | ||
| 30-08-2023 | PM | BLRX | BioLineRx Ltd. | 78.76 | -0.30 | -0.16 | -0.16 | BioLineRx GAAP EPS of -$0.02 [8/30/2023 7:02 AM] |
1.39 | 0.06 (4.51%) |
1.43 | 0.10 (7.52%) |
0.55 - 1.82 | 1,021,795 | 730,000 | 207,285 | ||
| 24-05-2023 | PM | 7:00 AM ET (May 24) |
BLRX | BioLineRx Ltd. | 89.83 | -0.15 | -0.14 | -0.10 | Biolinerx GAAP EPS of -$0.01 beats by $0.13 [5/24/2023 7:06 AM] |
1.56 | 0.06 (4.00%) |
1.49 | -0.01 (-0.67%) |
0.55 - 1.98 | 443,958 | 920,000 | 35,723 | |
| 22-03-2023 | PM | 7:00 AM ET (Mar 22) |
BLRX | BioLineRx Ltd. | 36.29 | -0.09 | -0.14 | -0.08 | biolinerx GAAP EPS of -$0.03 beats by $0.34 [3/22/2023 7:11 AM] |
0.7628 | 0.03 (3.54%) |
0.72 | -0.02 (-2.27%) |
0.55 - 1.98 | 850,291 | 320,000 | 9,344 | |
| 15-11-2022 | PM | 7:00 AM ET (Nov 15) |
BLRX | BioLineRx Ltd. | 39.38 | -0.15 | -0.16 | -0.23 | biolinerx GAAP EPS of -$0.01 [11/15/2022 7:05 AM] |
0.6790 | -0.03 (-4.85%) |
0.71 | 0.0 (0.08%) |
0.57 - 3.02 | 534,856 | 770,000 | 14,668 | |
| 16-08-2022 | PM | 7:00 AM ET (Aug 16) |
BLRX | BioLineRx Ltd. | 62.73 | -0.16 | -0.14 | -0.15 | biolinerx GAAP EPS of -$0.01 beats by $0.08 [8/16/2022 7:03 AM] |
1.80 | -0.11 (-5.73%) |
1.90 | -0.01 (-0.52%) |
1.01 - 3.15 | 510,969 | 220,000 | 2,197 | |
| 11-05-2022 | PM | 7:00 AM ET (May 11) |
BLRX | BioLineRx Ltd. | 55.31 | -0.10 | -0.15 | -0.27 | biolinerx GAAP EPS of -$0.02 [5/11/2022 7:09 AM] |
1.06 | -0.15 (-12.40%) |
1.18 | -0.03 (-2.48%) |
1.05 - 3.62 | 381,672 | 260,000 | 6,237 | |
| 16-03-2022 | PM | 7:00 AM ET (Mar 16) |
BLRX | BioLineRx Ltd. | 71.52 | -0.08 | -0.14 | -0.61 | biolinerx GAAP EPS of -$0.04 beats by $0.42 [3/16/2022 7:07 AM] |
1.48 | -0.04 (-2.96%) |
1.55 | 0.02 (1.31%) |
1.34 - 6.34 | 252,831 | 298,516 | 1,756 | |
| 18-11-2021 | PM | 7:00 AM ET (Nov 18) |
BLRX | BioLineRx Ltd. | 135.24 | -0.23 | -0.13 | -0.30 | biolinerx EPS beats by $0.11 [11/18/2021 7:06 AM] |
2.66 | -0.11 (-3.93%) |
2.83 | 0.06 (2.17%) |
2.17 - 6.34 | 418,701 | 260,000 | 20,764 | |
| 18-08-2021 | PM | 7:00 AM ET (Aug 18) |
BLRX | BioLineRx Ltd. | 142.77 | -0.15 | -0.12 | -0.45 | biolinerx EPS beats by $0.11 [8/18/2021 7:07 AM] |
2.76 | -0.13 (-4.53%) |
2.86 | -0.03 (-1.04%) |
1.40 - 6.34 | 1,380,095 | 490,000 | 80,783 | |
| 26-05-2021 | PM | 7:00 AM ET (May 26) |
BLRX | BioLineRx Ltd. | 137.91 | -0.27 | -0.15 | -0.60 | biolinerx EPS beats by $0.17 [5/26/2021 7:05 AM] |
2.91 | -0.04 (-1.36%) |
3.00 | 0.05 (1.69%) |
1.40 - 6.34 | 1,559,923 | 1,320,000 | 62,513 | |
| 23-02-2021 | PM | 7:00 AM ET (Feb 23) |
BLRX | BioLineRx Ltd. | 141.39 | -0.61 | -0.25 | -0.97 | biolinerx EPS beats by $1.06 [2/23/2021 7:04 AM] |
3.31 | -0.13 (-3.78%) |
3.46 | 0.02 (0.58%) |
1.06 - 4.23 | 1,971,396 | 2,294,448 | 143,924 | |
| 23-11-2020 | PM | 7:00 AM ET (Nov 23) |
BLRX | BioLineRx Ltd. | 49.04 | -0.30 | -0.36 | -0.40 | biolinerx EPS beats by $0.32 [11/23/2020 7:23 AM] |
2.29 | -0.35 (-13.26%) |
2.43 | -0.21 (-7.96%) |
1.06 - 3.30 | 2,169,045 | 1,149,808 | 218,935 | |
| 06-08-2020 | PM | 7:00 AM ET (Aug 6) |
BLRX | BioLineRx Ltd. | 44.27 | -0.45 | -0.60 | -0.04 | biolinerx EPS beats by $0.57 [8/6/2020 7:07 AM] |
1.98 | -0.36 (-15.50%) |
2.19 | -0.16 (-6.77%) |
1.06 - 4.08 | 951,949 | 577,291 | 45,532 | |
|
|
||||||||||||||||||
| 20-05-2020 | PM | 7:00 AM ET (May 20) |
BLRX | BioLineRx Ltd. | 23.98 | -0.60 | -0.83 | -0.75 | biolinerx EPS beats by $0.78 [5/20/2020 7:05 AM] |
1.92 | -0.22 (-10.28%) |
2.12 | -0.02 (-0.93%) |
1.06 - 6.45 | 156,200 | 51,893 | 8,350 | |
|
|
||||||||||||||||||